Historical return extremes for DexCom (DXCM) from 2005 to 2026
What if you bought at the best or worst time? Max profit, max drawdown, and total return since IPO.
| Scenario | Return | Start date | Start price | End date | End price | $1,000 becomes |
|---|---|---|---|---|---|---|
| Max profitMore info about Max profit | +46,755% | $0.35 | $162.82 | $468,546.76 | ||
| Max drawdownMore info about Max drawdown | -94.61% | $6.45 | $0.35 | $53.88 | ||
| Return since IPOMore info about Return since IPO | +2,464% | $2.94 | $75.37 | $25,636.05 |
- Max profitMore info about Max profit+46,755%$468,546.76
- Max drawdownMore info about Max drawdown-94.61%$53.88
- Return since IPOMore info about Return since IPO+2,464%$25,636.05
Each row shows the start and end dates and prices for the scenario, the period return, and the resulting outcome for a $1,000 investment in DexCom (DXCM). Max profit is the best buy-and-sell pair across the entire price history; max drawdown is the worst peak-to-trough decline; the last row tracks return from IPO to today. Prices are split- and dividend-adjusted closing prices — actual outcomes would differ due to fees, taxes, and slippage.
Frequently asked questions
Data & methodology
DexCom (DXCM) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement